LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Canertinib | 1.11 | uM | LJP6 | 1 | H09 | 72 | hr | 1657 | 4609 | 5505 | 0.8371 | 0.7670 |
| BT-20 | Canertinib | 1.11 | uM | LJP6 | 2 | H09 | 72 | hr | 1657 | 4595 | 5505 | 0.8346 | 0.7633 |
| BT-20 | Canertinib | 1.11 | uM | LJP6 | 3 | H09 | 72 | hr | 1657 | 4647 | 5505 | 0.8440 | 0.7769 |
| BT-20 | Celastrol | 1.11 | uM | LJP6 | 1 | G09 | 72 | hr | 1657 | 2246 | 5505 | 0.4079 | 0.1529 |
| BT-20 | Celastrol | 1.11 | uM | LJP6 | 2 | G09 | 72 | hr | 1657 | 2194 | 5505 | 0.3985 | 0.1394 |
| BT-20 | Celastrol | 1.11 | uM | LJP6 | 3 | G09 | 72 | hr | 1657 | 2636 | 5505 | 0.4788 | 0.2542 |
| BT-20 | CGP60474 | 1.11 | uM | LJP5 | 1 | F03 | 72 | hr | 1657 | 1527 | 5505 | 0.2774 | -0.0340 |
| BT-20 | CGP60474 | 1.11 | uM | LJP5 | 2 | F03 | 72 | hr | 1657 | 1481 | 5505 | 0.2690 | -0.0459 |
| BT-20 | CGP60474 | 1.11 | uM | LJP5 | 3 | F03 | 72 | hr | 1657 | 1540 | 5505 | 0.2797 | -0.0306 |
| BT-20 | CGP60474 | 1.11 | uM | LJP6 | 1 | G03 | 72 | hr | 1657 | 1029 | 5505 | 0.1869 | -0.1634 |
| BT-20 | CGP60474 | 1.11 | uM | LJP6 | 2 | G03 | 72 | hr | 1657 | 1097 | 5505 | 0.1993 | -0.1457 |
| BT-20 | CGP60474 | 1.11 | uM | LJP6 | 3 | G03 | 72 | hr | 1657 | 981 | 5505 | 0.1782 | -0.1759 |
| BT-20 | CHIR-99021 | 1.11 | uM | LJP6 | 1 | P15 | 72 | hr | 1657 | 5433 | 5505 | 0.9868 | 0.9811 |
| BT-20 | CHIR-99021 | 1.11 | uM | LJP6 | 2 | P15 | 72 | hr | 1657 | 5245 | 5505 | 0.9527 | 0.9323 |
| BT-20 | CHIR-99021 | 1.11 | uM | LJP6 | 3 | P15 | 72 | hr | 1657 | 5823 | 5505 | 1.0576 | 1.0825 |
| BT-20 | CP724714 | 1.11 | uM | LJP5 | 1 | A09 | 72 | hr | 1657 | 4566 | 5505 | 0.8293 | 0.7558 |
| BT-20 | CP724714 | 1.11 | uM | LJP5 | 2 | A09 | 72 | hr | 1657 | 4714 | 5505 | 0.8562 | 0.7943 |
| BT-20 | CP724714 | 1.11 | uM | LJP5 | 3 | A09 | 72 | hr | 1657 | 4426 | 5505 | 0.8039 | 0.7194 |
| BT-20 | CP466722 | 1.11 | uM | LJP5 | 1 | I09 | 72 | hr | 1657 | 5659 | 5505 | 1.0279 | 1.0398 |
| BT-20 | CP466722 | 1.11 | uM | LJP5 | 2 | I09 | 72 | hr | 1657 | 6027 | 5505 | 1.0947 | 1.1355 |
| BT-20 | CP466722 | 1.11 | uM | LJP5 | 3 | I09 | 72 | hr | 1657 | 5580 | 5505 | 1.0135 | 1.0193 |
| BT-20 | Crizotinib | 1.11 | uM | LJP5 | 1 | A21 | 72 | hr | 1657 | 4670 | 5505 | 0.8482 | 0.7828 |
| BT-20 | Crizotinib | 1.11 | uM | LJP5 | 2 | A21 | 72 | hr | 1657 | 4514 | 5505 | 0.8199 | 0.7423 |
| BT-20 | Crizotinib | 1.11 | uM | LJP5 | 3 | A21 | 72 | hr | 1657 | 4399 | 5505 | 0.7990 | 0.7124 |
| BT-20 | Momelotinib | 1.11 | uM | LJP5 | 1 | P09 | 72 | hr | 1657 | 4026 | 5505 | 0.7313 | 0.6155 |